Teradyne에 대한 매도 수량은 투자자에게 Teradyne의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Teradyne (NASDAQ:TER) 주식, 공매도 수량 보고

Teradyne

Teradyne, Inc. Common Stock

Teradyne, Inc.

Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.

Large Cap

News

Movers

Trading Ideas

ICLR

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 아이콘(NASDAQ:ICLR)의 주식은 예상보다 저조한 실적을 발표한 후 25.95% 급락했다. 여러 애널리스트들도 주가 목표를 하향 조정했다.

제뉴인 파츠 및 탑빌드가 지난주 최악의 성과를 보인 10개 대형주 중 일부 (10월 21일-10월 25일)

Analyst Color

Previews

Reiteration

Analyst Ratings

Tech

ASML

AVGO

INTC

MRVL

NVDA

NXPI

이번 주 엔비디아(NASDAQ:NVDA)의 실적에 초점을 맞춘 분석가들은 인공 지능(AI)의 부상, 중국의 강력한 수요, 지정학적 제한 등 주요 추세를 반도체 산업의 중요한 동인으로 강조한다.

엔비디아 주식, 반도체 부문은 AI 승자와 패자로 분리: 분석가는 &#39;무엇보다 AI를 고수&#39; 주장

DELL

LULU

MBLY

MEDP

SMCI

STLA

이들 12개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 에드워드 라이프사이언스(NYSE:EW)의 주가는 회사가 예상보다 나쁜 2분기 매출 실적을 보고하고 예상치보다 낮은 3분기 가이던스를 발표한 후 28.05% 급락했다. 회사는 또한 제나밸브(JenaValve)와 엔도트로닉스(Endotronix)를 인수했다. 몇몇 분석가들은 가격 전망을 대폭 낮췄다.

포드, 스텔란티스 및 델은 지난주 최악의 성과를 보인 12개 대형주 중 일부 (7월 21일부터 7월 27일)

Teradyne Inc

TERAFORCE TECH CORP by TeraForce Technology Corp.

TeraForce Technology Corp

TronEuropeRewardCoin

TerraCom Ltd

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharmaceuticals Inc

Tern PLC

TRASMISSIONE ELECTR ORD by Terna Rete Elettrica Nazionale SPA

Terna SpA

TERADYNE ORD

WIIM

AMAT

ENTG

KLAC

LRCX

MCHP

QCOM

SWKS

Shares of semiconductor stocks are trading lower. The sector may be under pressure following recent earnings from multiple companies in the sector.

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>ICON plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) shares plummeted 25.95% after the company reported <a href="https://www.benzinga.com//node/41500867" target="_blank" rel="noreferrer noopener">worse-than-expected results</a>. Several analysts also cut the <a href="https://www.benzinga.com/quote/iclr/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) stock tumbled 20.21% after it reported mixed third-quarter results and cut its <a href="https://www.benzinga.com//node/41455012" target="_blank" rel="noreferrer noopener">FY24 EPS below estimates</a>. Multiple analysts cut the <a href="https://www.benzinga.com/quote/gpc/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) shares dipped 15.97% after the company reported <a href="https://www.benzinga.com//node/41503948" target="_blank" rel="noreferrer noopener">third-quarter financial results</a>. Analysts trimmed the <a href="https://www.benzinga.com/quote/nem/analyst-ratings" target="_blank" rel="noreferrer noopener">stock&#8217;s price target</a>.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) stock lost 14.71% last week. Several healthcare stocks and hospital operators fell in possible sympathy with HCA Healthcare, which declined on Q3 earnings.</li>
<li>Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) stock fell 14.33% last week after the company reported <a href="https://www.benzinga.com//node/41530333" target="_blank" rel="noreferrer noopener">Q3 financial results</a>.</li>
<li>HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) stock fell 12.51% after reporting <a href="https://www.benzinga.com//node/41544243" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 financial results</a>. The company expects Hurricane Helene&#8217;s impact to continue in 2025.</li>
<li>TopBuild Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>) stock lost 11.48% last week as homebuilding stocks <a href="https://www.benzinga.com//node/41317881" target="_blank" rel="noreferrer noopener">took a beating</a> due to Hurricane Milton&#8217;s impact.</li>
<li>Carlisle Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>) fell 11.45% last week on <a href="https://www.benzinga.com//node/41529849" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 performance</a>.</li>
<li>Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) stock declined 11.34% after it reported <a href="https://www.benzinga.com//node/41503363" target="_blank" rel="noreferrer noopener">third-quarter financial results</a>. Some analysts trimmed the <a href="https://www.benzinga.com/quote/ter/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Comfort Systems USA, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) stock declined 11.27% after the company reported <a href="https://www.benzinga.com//node/41530044" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 sales results</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/10/41560908/tesla-li-auto-and-microstrategy-are-among-top-10-large-cap-gainers-last-week-oct-21-oct-25-are-the">Tesla, Li Auto And MicroStrategy Are Among Top 10 Large Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?</a></li>
</ul>

Genuine Parts Company, Universal Health Services, And TopBuild Are Among Top 10 Large Cap Losers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?

Craig-Hallum analyst Christian Schwab maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Hold and lowers the price target from $124 to $111.

Price Target

Craig-Hallum Maintains Hold on Teradyne, Lowers Price Target to $111

Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $135.0, with a high estimate of $160.00 and a low estimate of $117.00. Observing a 2.66% increase, the current average has risen from the previous average price target of $131.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1729875620_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Teradyne. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gus Richard</td>
<td>Northland Capital Markets</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$117.00</td>
<td>$126.00</td>
</tr>
<tr>
<td>Brian Chin</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$125.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$133.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>C J Muse</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Overweight</td>
<td>$160.00</td>
<td>-</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$120.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Teradyne. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Teradyne compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Teradyne's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Teradyne's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TER/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Teradyne analyst ratings.</a>
<h2>About Teradyne</h2>
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
<h3>Teradyne's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Teradyne showcased positive performance, achieving a revenue growth rate of 6.64% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Teradyne's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 25.52%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.04%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Teradyne's ROA excels beyond industry benchmarks, reaching 5.29%. This signifies efficient management of assets and strong financial health.
Debt Management: Teradyne's debt-to-equity ratio is below the industry average. With a ratio of 0.03, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Evaluating Teradyne: Insights From 5 Financial Analysts

Northland Capital Markets analyst Gus Richard maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Market Perform and lowers the price target from $126 to $117.

Northland Capital Markets Maintains Market Perform on Teradyne, Lowers Price Target to $117

Stifel analyst Brian Chin maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Hold and lowers the price target from $140 to $125.

Stifel Maintains Hold on Teradyne, Lowers Price Target to $125

Baird analyst Richard Eastman maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Outperform and lowers the price target from $140 to $133.

Baird Maintains Outperform on Teradyne, Lowers Price Target to $133

Teradyne shares are trading lower. The company reported Q3 financial results.

Guidance

Teradyne Expects Q4 Revenue Of $710M - $760M, Adj EPS Of $0.80 - $0.97

Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.78 by 15.38 percent. This is a 12.5 percent increase over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $737.30 million which beat the analyst consensus estimate of $716.40 million by 2.92 percent. This is a 4.77 percent increase over sales of $703.73 million the same period last year.

Earnings

Earnings Beats

Teradyne Q3 2024 Adj EPS $0.90 Beats $0.78 Estimate, Sales $737.30M Beat $716.40M Estimate

Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Teradyne to report an earnings per share (EPS) of $0.78.
Investors in Teradyne are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
The company's EPS beat by $0.09 in the last quarter, leading to a 13.38% drop in the share price on the following day.
Here's a look at Teradyne's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.77</td>
<td>0.33</td>
<td>0.71</td>
<td>0.73</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.86</td>
<td>0.51</td>
<td>0.79</td>
<td>0.80</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-13.0%</td>
<td>8.0%</td>
<td>-8.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729609264_0_0.png" alt="eps graph" />
<h3>Performance of Teradyne Shares</h3>
Shares of Teradyne were trading at $125.93 as of October 21. Over the last 52-week period, shares are up 43.2%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Insights Shared by Analysts on Teradyne</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Teradyne.
The consensus rating for Teradyne is Neutral, based on 8 analyst ratings. With an average one-year price target of $149.62, there's a potential 18.81% upside.
<h3>Peer Ratings Comparison</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Entegris, Enphase Energy and Onto Innovation, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>As per analysts' assessments, Entegris is favoring an Buy trajectory, with an average 1-year price target of $143.83, suggesting a potential 14.21% upside.</li>
<li>The consensus outlook from analysts is an Neutral trajectory for Enphase Energy, with an average 1-year price target of $112.53, indicating a potential 10.64% downside.</li>
<li>As per analysts' assessments, Onto Innovation is favoring an Outperform trajectory, with an average 1-year price target of $255.0, suggesting a potential 102.49% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for Entegris, Enphase Energy and Onto Innovation, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Teradyne</td>
<td>Neutral</td>
<td>6.64%</td>
<td>$425.84M</td>
<td>7.04%</td>
</tr>
<tr>
<td>Entegris</td>
<td>Buy</td>
<td>-9.81%</td>
<td>$375.82M</td>
<td>1.95%</td>
</tr>
<tr>
<td>Enphase Energy</td>
<td>Neutral</td>
<td>-57.33%</td>
<td>$137.17M</td>
<td>1.20%</td>
</tr>
<tr>
<td>Onto Innovation</td>
<td>Outperform</td>
<td>27.10%</td>
<td>$128.24M</td>
<td>2.93%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Teradyne ranks highest in revenue growth among its peers. It also leads in gross profit margin. However, it has the lowest return on equity compared to its peers.
<h3>All You Need to Know About Teradyne</h3>
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
<h3>Teradyne: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Teradyne showcased positive performance, achieving a revenue growth rate of 6.64% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Teradyne's net margin excels beyond industry benchmarks, reaching 25.52%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.04%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Teradyne's ROA excels beyond industry benchmarks, reaching 5.29%. This signifies efficient management of assets and strong financial health.
Debt Management: Teradyne's debt-to-equity ratio is below the industry average. With a ratio of 0.03, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/TER/earnings">To track all earnings releases for Teradyne visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Teradyne's Earnings Preview

ARM,QCOM,NVDA,MU,AMD,TSM,AVGO,NXPI,LRCX,INTC,ASML,ON,RMBS,LSCC,GFS,TSEM,SIMO,ADI,KLAC,MCHP,STM,AMAT

ACLS

ACMR

ALGM

CAMT

FORM

FSLR

KLIC

LSCC

MKSI

MPWR

NVMI

RMBS

SIMO

SITM

TSEM

UCTT

Shares of chip stocks are trading lower in sympathy with ASML, which fell after issuing soft guidance. Some stocks in the sector may also be down on reports indicating the US is discussing curbing chip exports to some countries.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock&#39;s price, do they really matter?
Let&#39;s take a look at what these Wall Street heavyweights have to say about Teradyne (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ter#NASDAQ">TER</a>) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.
Teradyne currently has an average brokerage recommendation of 1.81, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 16 brokerage firms. An ABR of 1.81 approximates between Strong Buy and Buy.
Of the 16 recommendations that derive the current ABR, 10 are Strong Buy, representing 62.5% of all recommendations.
<h2>Brokerage Recommendation Trends for TER</h2>
<img alt="Broker Rating Breakdown Chart for TER" class="chart" src="https://staticx-tuner.zacks.com/images/yesopchart/brokerage_bar/TER_10112024.png" style="width:100%" title="" /> 
The ABR suggests buying Teradyne, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.
Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every &quot;Strong Sell&quot; recommendation, brokerage firms assign five &quot;Strong Buy&quot; recommendations.
In other words, their interests aren&#39;t always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock&#39;s price movement.
Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock&#39;s price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.
<h2>Zacks Rank Should Not Be Confused With ABR</h2>
Although both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.
Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.
In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.
There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.
<h2>Should You Invest in TER?</h2>
Looking at the earnings estimate revisions for Teradyne, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $3.02.
Analysts&#39; steady views regarding the company&#39;s earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Teradyne.
It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Teradyne.
<a href="https://www.zacks.com/stock/news/2349267/teradyne-ter-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-BENZ-FT-fundamental_analysis|average_broker_rating-2349267">To read this article on Zacks.com click here.</a>

Markets

Teradyne Is Considered a Good Investment by Brokers: Is That True?

Shares of semiconductor stocks are trading higher. The sector may be rebounding after falling amid a broader market dip on Tuesday.

MTSI

SELX

WOLF

Shares of companies in the broader semiconductor and chip sector are trading lower amid overall market weakness after Iran launched a missile attack on Israel.

Teradyne's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TER#NYSE">TER</a>) short percent of float has risen 6.32% since its last report. The company recently reported that it has 4.16 million shares sold short, which is 3.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.34 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Teradyne Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727787626_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Teradyne has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Teradyne's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Teradyne's peer group average for short interest as a percentage of float is 6.81%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Teradyne?

OLED

Shares of semiconductor and chip stocks are trading higher following Wednesday's rate cut, which has lifted growth stocks and rate-sensitive sectors such as tech.

Small Business

Teradyne Robotics And Siemens Announce Strategic Collaboration To Showcase Future Of Automation At Siemens Experience Center In MxD Innovation Hub, Chicago

AAOI

QRVO

Shares of semiconductor and chip stocks are trading lower. The sector has been volatile recently as investors assess economic data, potential Fed policy and the sector's year-to-date performance.

Shares of semiconductor stocks are trading higher amid strong recent economic data and in possible sympathy with Nvidia following CEO Jensen Huang's recent comments on demand and after Vice President Harris spoke of investment in American-based companies to win the technology race during the Presidential Debate.

In a report released today, Gus Richard from Northland Securities maintained a Hold rating on Teradyne (TER – Research Report), with a price target...

Northland Securities Remains a Hold on Teradyne (TER)

Teradyne (TER – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Krish Sankar from TD Cowen m...

Positive Investment Outlook for Teradyne Driven by Strong AI and SoC Market Performance Despite Short-Term Challenges

20:06 EDT Cathie Wood's ARK Investment buys 132.5K shares of Teradyne (TER) today Published first on TheFly – the ultimate source for real-time, ma...

Cathie Wood's ARK Investment buys 132.5K shares of Teradyne today

TimesSquare U.S. Focus Growth Strategy Q3 2024 Commentary

Analyst Joseph Moore of Morgan Stanley reiterated a Hold rating on Teradyne (TER – Research Report), reducing the price target to $121.00. Joseph M...

Teradyne: Balancing Strong Memory Test Gains with Robotics Challenges and Uncertain Future Outlook

KeyBanc analyst Steve Barger maintained a Buy rating on Teradyne (TER – Research Report) today. The company's shares closed yesterday at $110.72. A...

KeyBanc Sticks to Its Buy Rating for Teradyne (TER)

Evercore ISI analyst Vedvati Shrotre reiterated a Buy rating on Teradyne (TER – Research Report) today and set a price target of $135.00. The compa...

New Buy Rating for Teradyne (TER), the Technology Giant

Craig-Hallum analyst Christian Schwab lowered the firm's price target on Teradyne (TER) to $111 from $124 and keeps a Hold rating on the shares fol...

Teradyne price target lowered to $111 from $124 at Craig-Hallum

DBS analyst Amanda Tan has maintained their bullish stance on TER stock, giving a Buy rating today. Amanda Tan's rating is based on Teradyne's prom...

Teradyne's Buy Rating Driven by Robust Semiconductor Growth and Promising Industrial Automation Prospects

Parnassus Mid Cap Growth Fund  Q3 2024 Commentary

ADSK

BILL

CDNS

CRWD

CTAS

GWRE

JBHT

LPLA

MELI

ORLY

ROST

TEAM

VEEV

VRSK

Press Releases

Teradyne Declares Quarterly Cash Dividend

Teradyne Robotics and Siemens Announce a Strategic Collaboration for the Siemens Experience Center at MxD to Showcase the Future of Automation in the U.S.

Universal Robots Updates Payload Capacity for UR20 and UR30

Glenn Farris Joins LitePoint as Vice President of Worldwide Sales

Teradyne to Announce Third Quarter 2024 Results

Universal Robots Expands 'Beyond the Welding Cart' at FABTECH 2024

New MiR Fleet Enterprise Software Raises the Bar in Scalability and Cybersecurity for Autonomous Mobile Robots

Universal Robots Unveils Its AI Accelerator, Enabling a New Wave of AI-Powered Cobot Innovations

LitePoint and Pegatron 5G Collaborate to Drive the Future of 5G Performance

Teradyne Reports Third Quarter 2024 Results

Axcelis Technologies, Inc. - Common Stock

Axcelis Technologies

ACM Research, Inc. - Class A Common Stock

ACM Research

Aehr Test System

Applied Mat

Amkor Tech

ASML Holding N.V. - New York Registry Shares

ASML Holding

Atomera

Cohu

DAQO New Energy Corp. American Depositary Shares, each representing five ordinary shares

Comments

Teradyne

매도 수량

Teradyne (NASDAQ:TER) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌